| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | KDEL sequence binding | 4.07e-07 | 3 | 149 | 3 | GO:0005046 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 ABCA2 ABCA3 ATP7B MYO1A MYO7A TMEM94 HSPH1 SRCAP DNAH7 ABCA9 ATP2C1 ENTPD2 CCT8 KIF5A KIF5C POLQ | 3.49e-06 | 614 | 149 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | ER retention sequence binding | 4.03e-06 | 5 | 149 | 3 | GO:0046923 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.76e-05 | 109 | 149 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 ABCA2 ABCA3 ATP7B SRCAP DNAH7 ABCA9 ATP2C1 ENTPD2 CCT8 KIF5A KIF5C POLQ | 2.74e-05 | 441 | 149 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA1 ABCA2 ABCA3 ATP7B SRCAP DNAH7 ABCA9 ATP2C1 ENTPD2 CCT8 GNB4 KIF5A KIF5C GNB1 POLQ ARL14 | 2.27e-04 | 775 | 149 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.59e-04 | 118 | 149 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 3.29e-04 | 4 | 149 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 3.85e-04 | 178 | 149 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.86e-04 | 49 | 149 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA1 ABCA2 ABCA3 ATP7B SRCAP DNAH7 ABCA9 ATP2C1 ENTPD2 CCT8 GNB4 KIF5A KIF5C GNB1 POLQ ARL14 | 5.43e-04 | 839 | 149 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | collagen binding involved in cell-matrix adhesion | 5.45e-04 | 5 | 149 | 2 | GO:0098639 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA1 ABCA2 ABCA3 ATP7B SRCAP DNAH7 ABCA9 ATP2C1 ENTPD2 CCT8 GNB4 KIF5A KIF5C GNB1 POLQ ARL14 | 5.50e-04 | 840 | 149 | 16 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA1 ABCA2 ABCA3 ATP7B SRCAP DNAH7 ABCA9 ATP2C1 ENTPD2 CCT8 GNB4 KIF5A KIF5C GNB1 POLQ ARL14 | 5.50e-04 | 840 | 149 | 16 | GO:0016818 |
| GeneOntologyMolecularFunction | DNA-directed DNA polymerase activity | 8.30e-04 | 25 | 149 | 3 | GO:0003887 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCA1 ABCA2 ABCA3 ATP7B TMEM94 SLC6A19 SLC28A3 ABCA9 ATP2C1 SLC30A5 SLC12A1 | 9.24e-04 | 477 | 149 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | cholesterol binding | 9.24e-04 | 58 | 149 | 4 | GO:0015485 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 1.16e-03 | 28 | 149 | 3 | GO:0140326 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 7.90e-05 | 61 | 151 | 5 | GO:0030660 | |
| Domain | ER_ret_rcpt | 4.98e-07 | 3 | 149 | 3 | IPR000133 | |
| Domain | ER_lumen_recept | 4.98e-07 | 3 | 149 | 3 | PF00810 | |
| Domain | ER_LUMEN_RECEPTOR_1 | 4.98e-07 | 3 | 149 | 3 | PS00951 | |
| Domain | ER_LUMEN_RECEPTOR_2 | 4.98e-07 | 3 | 149 | 3 | PS00952 | |
| Domain | ABC_A | 1.83e-06 | 12 | 149 | 4 | IPR026082 | |
| Domain | Quinoprotein_ADH-like_supfam | 6.37e-05 | 53 | 149 | 5 | IPR011047 | |
| Domain | DUF1908 | 3.75e-04 | 4 | 149 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 3.75e-04 | 4 | 149 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 3.75e-04 | 4 | 149 | 2 | IPR023142 | |
| Domain | - | 3.75e-04 | 4 | 149 | 2 | 1.20.1480.20 | |
| Domain | ABC_tran | 5.76e-04 | 48 | 149 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 5.76e-04 | 48 | 149 | 4 | PS50893 | |
| Domain | Guanine_nucleotide-bd_bsu | 6.22e-04 | 5 | 149 | 2 | IPR016346 | |
| Domain | ABC_TRANSPORTER_1 | 6.24e-04 | 49 | 149 | 4 | PS00211 | |
| Domain | WD40_repeat_dom | 6.44e-04 | 297 | 149 | 9 | IPR017986 | |
| Domain | ABC_transporter-like | 6.74e-04 | 50 | 149 | 4 | IPR003439 | |
| Domain | Znf_C2H2_jaz | 6.86e-04 | 22 | 149 | 3 | IPR022755 | |
| Domain | zf-C2H2_jaz | 6.86e-04 | 22 | 149 | 3 | PF12171 | |
| Domain | HELP | 9.29e-04 | 6 | 149 | 2 | PF03451 | |
| Domain | - | 9.29e-04 | 6 | 149 | 2 | 2.140.10.10 | |
| Domain | Quinoprotein_ADH-like_fam | 9.29e-04 | 6 | 149 | 2 | IPR027295 | |
| Domain | HELP | 9.29e-04 | 6 | 149 | 2 | IPR005108 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NPC1 FOXO3 ABCA2 HIVEP2 MYO7A TMEM94 RAP1GAP2 REV3L SRCAP ADCY9 DIP2A FAT1 HEG1 KLHL25 PI4KA RRP12 ENTPD2 ZNF516 MAD1L1 C19orf44 PDCD11 AP1G2 GCN1 | 6.65e-10 | 1105 | 153 | 23 | 35748872 |
| Pubmed | Cell-type-specific differences in KDEL receptor clustering in mammalian cells. | 8.35e-08 | 3 | 153 | 3 | 32645101 | |
| Pubmed | A molecular specificity code for the three mammalian KDEL receptors. | 8.35e-08 | 3 | 153 | 3 | 18086916 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 9118249 | ||
| Pubmed | TENT4B DSG2 MUC16 RICTOR ERBIN DNAH7 ADCY9 DMXL1 FAT1 SLC30A5 PI4KA ZNF638 CCT8 PCCB GCN1 ARL14 | 3.69e-07 | 777 | 153 | 16 | 35844135 | |
| Pubmed | Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. | 2.88e-06 | 7 | 153 | 3 | 15479741 | |
| Pubmed | 4.60e-06 | 8 | 153 | 3 | 24293640 | ||
| Pubmed | 5.56e-06 | 216 | 153 | 8 | 31519766 | ||
| Pubmed | KDELR2 KNTC1 KDELR3 RANBP2 MYO1A ACTBL2 HSPH1 DBNL STOX1 PFKM SRCAP ERBIN LUZP1 ENTPD2 KDELR1 KIF5A KIF5C GNB1 POLQ MNDA | 5.74e-06 | 1442 | 153 | 20 | 35575683 | |
| Pubmed | RANBP2 ARHGAP24 GRM5 ERBIN LUZP1 PI4KA ZNF516 MAD1L1 CCT8 KIF5A KIF5C EML1 SPATS2 GNB1 CDH2 WNK3 | 5.87e-06 | 963 | 153 | 16 | 28671696 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | FOXO3 RANBP2 DSG2 HSPH1 DBNL CPD PFKM DNAH7 LUZP1 MAST4 CPNE3 CCT8 KIF5C GNB1 PCCB | 5.96e-06 | 853 | 153 | 15 | 28718761 |
| Pubmed | Widespread and dynamic translational control of red blood cell development. | 6.25e-06 | 102 | 153 | 6 | 27899360 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO3 PDE3B HIVEP2 DSG2 RAB11FIP2 DBNL RICTOR ERBIN DNAH7 LUZP1 MAST4 PI4KA MAD1L1 KIF5C WNK3 | 6.66e-06 | 861 | 153 | 15 | 36931259 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOXO3 KDELR2 PDE3B HIVEP2 ABHD2 SLC22A23 LAMA3 CPD ZSWIM1 ERBIN ATP2C1 PTPRE HPN MAD1L1 ZNF638 MAST1 XYLB KIF5C SPATS2 STX17 | 9.18e-06 | 1489 | 153 | 20 | 28611215 |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.10e-05 | 170 | 153 | 7 | 23314748 | |
| Pubmed | RANBP2 ACTBL2 XPO4 RICTOR CPD ERBIN ADCY9 LUZP1 PTPRE PI4KA RRP12 ZNF638 GNB4 STX17 GCN1 FBXW7 | 1.69e-05 | 1049 | 153 | 16 | 27880917 | |
| Pubmed | The KIF3 motor transports N-cadherin and organizes the developing neuroepithelium. | 1.78e-05 | 12 | 153 | 3 | 15834408 | |
| Pubmed | Impaired pancreatic development in Hif2-alpha deficient mice. | 1.78e-05 | 12 | 153 | 3 | 20678473 | |
| Pubmed | DSG2 TMEM94 RAB11FIP2 RICTOR CPD ERBIN ADCY9 SLC30A5 PI4KA CDH2 | 1.87e-05 | 421 | 153 | 10 | 36976175 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 15192019 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 16181639 | ||
| Pubmed | ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease. | 1.92e-05 | 2 | 153 | 2 | 15649702 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 21586796 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 38019257 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 32838755 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 1282354 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 25352669 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 28075014 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 10970803 | ||
| Pubmed | Allosteric inhibition of hypoxia inducible factor-2 with small molecules. | 1.92e-05 | 2 | 153 | 2 | 23434853 | |
| Pubmed | A Golgi-based KDELR-dependent signalling pathway controls extracellular matrix degradation. | 1.92e-05 | 2 | 153 | 2 | 25682866 | |
| Pubmed | Cloning of two novel ABC transporters mapping on human chromosome 9. | 1.92e-05 | 2 | 153 | 2 | 8088782 | |
| Pubmed | Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. | 1.92e-05 | 2 | 153 | 2 | 19902402 | |
| Pubmed | HIF-1beta determines ABCA1 expression under hypoxia in human macrophages. | 1.92e-05 | 2 | 153 | 2 | 19828131 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 10880563 | ||
| Pubmed | Artificial ligand binding within the HIF2alpha PAS-B domain of the HIF2 transcription factor. | 1.92e-05 | 2 | 153 | 2 | 19129502 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 9398442 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 30760704 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 25201756 | ||
| Pubmed | Desmoglein-2 interaction is crucial for cardiomyocyte cohesion and function. | 1.92e-05 | 2 | 153 | 2 | 25213555 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 20571217 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 12215451 | ||
| Pubmed | HSPH1 RAB11FIP2 DBNL STOX1 ERBIN LUZP1 MAST1 SPATS2 GNB1 CDH2 | 2.24e-05 | 430 | 153 | 10 | 32581705 | |
| Pubmed | Desmoglein 2 regulates cardiogenesis by restricting hematopoiesis in the developing murine heart. | 2.31e-05 | 13 | 153 | 3 | 34737300 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 EML4 HSPH1 DBNL RICTOR PFKM SRCAP ERBIN LUZP1 POLR3A PI4KA RRP12 CPNE3 ZNF638 CCT8 PDCD11 AP1G2 GCN1 | 3.02e-05 | 1353 | 153 | 18 | 29467282 |
| Pubmed | 3.21e-05 | 41 | 153 | 4 | 8724849 | ||
| Pubmed | 3.33e-05 | 202 | 153 | 7 | 24639526 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 4.40e-05 | 288 | 153 | 8 | 31501420 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 17693257 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 21814490 | ||
| Pubmed | Hepatic Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) regulates metabolism in mice. | 5.75e-05 | 3 | 153 | 2 | 29190746 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 25627682 | ||
| Pubmed | Cloning and localization of a conventional kinesin motor expressed exclusively in neurons. | 5.75e-05 | 3 | 153 | 2 | 7514426 | |
| Pubmed | Altered DNA binding specificity of Arnt by selection of partner bHLH-PAS proteins. | 5.75e-05 | 3 | 153 | 2 | 15190133 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 22179027 | ||
| Pubmed | The ancient regulatory-protein family of WD-repeat proteins. | 5.75e-05 | 3 | 153 | 2 | 8090199 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 14668441 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 23796364 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 21768290 | ||
| Pubmed | Hypoxia-inducible factors regulate filaggrin expression and epidermal barrier function. | 5.75e-05 | 3 | 153 | 2 | 24999590 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 30068641 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 17553802 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 25855602 | ||
| Pubmed | N-cadherin acts upstream of VE-cadherin in controlling vascular morphogenesis. | 5.75e-05 | 3 | 153 | 2 | 15809310 | |
| Pubmed | Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. | 5.75e-05 | 3 | 153 | 2 | 9436976 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 26245371 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 15681833 | ||
| Pubmed | Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells. | 5.75e-05 | 3 | 153 | 2 | 22285861 | |
| Pubmed | Inositol pyrophosphates promote MYC polyubiquitination by FBW7 to regulate cell survival. | 5.75e-05 | 3 | 153 | 2 | 33821962 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 15653678 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 9000051 | ||
| Pubmed | Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes. | 5.75e-05 | 3 | 153 | 2 | 19302442 | |
| Pubmed | Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation. | 5.75e-05 | 3 | 153 | 2 | 28241820 | |
| Pubmed | Molecular imaging: into in vivo interaction of HIF-1alpha and HIF-2alpha with ARNT. | 5.75e-05 | 3 | 153 | 2 | 19845609 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 16554418 | ||
| Pubmed | Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression. | 5.75e-05 | 3 | 153 | 2 | 15689487 | |
| Pubmed | 6.05e-05 | 222 | 153 | 7 | 37071664 | ||
| Pubmed | NR2C1 ACTR8 HSPH1 SRCAP ERBIN SETDB1 FAT1 ARNT ZNF644 RRP12 ZNF516 UBXN7 ZNF638 PDCD11 GNB4 PCCB LRIF1 FBXW7 | 6.11e-05 | 1429 | 153 | 18 | 35140242 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ABCA2 ACTBL2 HSPH1 RICTOR XPNPEP1 SRCAP CPNE3 CCT8 EML1 PCCB GCN1 HYDIN MYO16 | 6.25e-05 | 807 | 153 | 13 | 30575818 |
| Pubmed | RANBP2 HIVEP2 RAP1GAP2 LAMA3 ERBIN SETDB1 KIF5A COG5 GCN1 EPAS1 | 6.27e-05 | 486 | 153 | 10 | 20936779 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KNTC1 AASDH SRCAP LUZP1 SETDB1 ARNT PI4KA ZNF644 ZNF516 CPNE3 LRIF1 | 6.31e-05 | 588 | 153 | 11 | 38580884 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NPC1 FAM234B RANBP2 PDE3B DSG2 HSPH1 CPD ATP2C1 PI4KA RRP12 GNB1 COG5 GCN1 WNK3 | 7.66e-05 | 942 | 153 | 14 | 31073040 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NPC1 KDELR3 FAM234B ITGA11 ABCA2 ATR DSG2 HSPH1 CPD DMXL1 FAT1 HEG1 RRP12 KDELR1 CCT8 CDH2 | 8.43e-05 | 1201 | 153 | 16 | 35696571 |
| Pubmed | TMEM94 RAP1GAP2 CSMD3 ERBIN SETDB1 ZNF644 RRP12 MAST1 ADGRL3 | 8.53e-05 | 407 | 153 | 9 | 12693553 | |
| Pubmed | 9.14e-05 | 164 | 153 | 6 | 32409323 | ||
| Pubmed | Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. | 1.03e-04 | 55 | 153 | 4 | 24200680 | |
| Pubmed | 1.04e-04 | 418 | 153 | 9 | 34709266 | ||
| Pubmed | 1.05e-04 | 21 | 153 | 3 | 25340332 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 PDE3B MYO7A HSPH1 C11orf24 SLC28A3 STOX1 REV3L QRICH2 DIP2A PI4KA CCT8 | 1.08e-04 | 736 | 153 | 12 | 29676528 |
| Pubmed | 1.15e-04 | 4 | 153 | 2 | 16192278 | ||
| Pubmed | 1.15e-04 | 4 | 153 | 2 | 17020879 | ||
| Pubmed | 1.15e-04 | 4 | 153 | 2 | 20129696 | ||
| Pubmed | Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. | 1.15e-04 | 4 | 153 | 2 | 15371328 | |
| Pubmed | HIF-1 alpha is required for solid tumor formation and embryonic vascularization. | 1.15e-04 | 4 | 153 | 2 | 9606183 | |
| Pubmed | Involvement of vessels and PDGFB in muscle splitting during chick limb development. | 1.15e-04 | 4 | 153 | 2 | 17553906 | |
| Pubmed | 1.15e-04 | 4 | 153 | 2 | 1543505 | ||
| Pubmed | 1.15e-04 | 4 | 153 | 2 | 15117738 | ||
| Pubmed | 1.15e-04 | 4 | 153 | 2 | 24639525 | ||
| Pubmed | The role of G protein beta subunits in the release of ATP from human erythrocytes. | 1.15e-04 | 4 | 153 | 2 | 12512701 | |
| Pubmed | 1.15e-04 | 4 | 153 | 2 | 26160453 | ||
| Interaction | OPALIN interactions | KDELR2 KNTC1 KDELR3 ATR XPO4 DIP2A ATP2C1 SLC30A5 PI4KA KDELR1 GCN1 | 5.19e-07 | 209 | 151 | 11 | int:OPALIN |
| Cytoband | 1q21 | 2.53e-04 | 91 | 153 | 4 | 1q21 | |
| Cytoband | 9q31.1 | 3.53e-04 | 41 | 153 | 3 | 9q31.1 | |
| Cytoband | 18q11.2 | 5.28e-04 | 47 | 153 | 3 | 18q11.2 | |
| GeneFamily | ATP binding cassette subfamily A | 9.15e-07 | 14 | 102 | 4 | 805 | |
| GeneFamily | WD repeat domain containing | 1.18e-04 | 262 | 102 | 8 | 362 | |
| Coexpression | HALLMARK_BILE_ACID_METABOLISM | 4.00e-06 | 112 | 151 | 7 | M5948 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FOXO3 RANBP2 HIVEP2 ATR REV3L ADCY9 SETDB1 FAT1 HEG1 ATP2C1 MAD1L1 UBXN7 ZNF638 KIF5C COG5 CDH2 MNAT1 | 9.49e-06 | 856 | 151 | 17 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 9.95e-06 | 85 | 151 | 6 | M10575 | |
| Coexpression | GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP | 2.11e-05 | 199 | 151 | 8 | M9754 | |
| Coexpression | GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP | 2.18e-05 | 200 | 151 | 8 | M9737 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 2.18e-05 | 200 | 151 | 8 | M7525 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GPR155 ABCA3 ARHGAP24 MYO7A RAP1GAP2 LAMA3 RICTOR REV3L GRM5 CSMD3 MAST4 ERAP2 MAST1 KIF5C GRIN3A HYDIN WNK3 ADGRL3 | 7.09e-05 | 1106 | 151 | 18 | M39071 |
| Coexpression | GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 7.75e-05 | 177 | 151 | 7 | M7637 | |
| Coexpression | GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP | 8.03e-05 | 178 | 151 | 7 | M383 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | FOXO3 RANBP2 ATR CPD PFKM ADCY9 FAT1 ATP2C1 CPNE3 ZNF638 COG5 | 1.14e-04 | 481 | 151 | 11 | M3898 |
| Coexpression | LU_EZH2_TARGETS_DN | NPC1 NR2C1 FAM234B DSG2 RAB11FIP2 HEG1 ATP2C1 PTPRE PI4KA POLQ | 1.14e-04 | 400 | 151 | 10 | M2140 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | KDELR2 C11orf24 FAM200B POLR3A SLC30A5 MAD1L1 KDELR1 ZNF638 PDCD11 SPATS2 GCN1 FBXW7 | 1.27e-04 | 573 | 151 | 12 | M41006 |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | C2orf69 ABCA2 RAP1GAP2 CSMD3 POLR3A MAST4 UBXN7 MAST1 CDH2 MYO16 FBXW7 | 1.29e-04 | 488 | 151 | 11 | M39104 |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_UP | 1.46e-04 | 196 | 151 | 7 | M7973 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 1.51e-04 | 197 | 151 | 7 | M4421 | |
| Coexpression | GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN | 1.56e-04 | 198 | 151 | 7 | M3248 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 1.56e-04 | 198 | 151 | 7 | M4415 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN | 1.56e-04 | 198 | 151 | 7 | M4441 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_DN | 1.61e-04 | 199 | 151 | 7 | M3750 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.61e-04 | 199 | 151 | 7 | M5201 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 1.61e-04 | 199 | 151 | 7 | M6519 | |
| Coexpression | GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN | 1.66e-04 | 200 | 151 | 7 | M9303 | |
| Coexpression | GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 1.66e-04 | 200 | 151 | 7 | M7198 | |
| Coexpression | GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN | 1.66e-04 | 200 | 151 | 7 | M5724 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN | 1.66e-04 | 200 | 151 | 7 | M5679 | |
| Coexpression | GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP | 1.66e-04 | 200 | 151 | 7 | M4393 | |
| Coexpression | GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN | 1.66e-04 | 200 | 151 | 7 | M4302 | |
| Coexpression | FEVR_CTNNB1_TARGETS_UP | KDELR3 ABCA3 DSG2 MYO7A ABHD2 SLC22A23 LAMA3 C11orf24 SLC28A3 IP6K1 PTPRE SULT2B1 AP3M2 | 1.83e-04 | 688 | 151 | 13 | M2342 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.99e-04 | 145 | 151 | 6 | M1810 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000 | GALC DSG2 RAB11FIP2 REV3L CSMD3 PANK1 DNAH7 SLC30A5 TSHZ1 ADGRL3 | 1.43e-05 | 259 | 148 | 10 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k1_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_200 | 1.81e-05 | 23 | 148 | 4 | gudmap_developingGonad_e18.5_epididymis_200_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | GALC DSG2 RAB11FIP2 GSAP REV3L PANK1 DNAH7 SLC30A5 TAF7L TSHZ1 WNK3 ADGRL3 | 2.72e-05 | 404 | 148 | 12 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#1_top-relative-expression-ranked_500 | 4.24e-05 | 91 | 148 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k1_500 | |
| CoexpressionAtlas | B cells, B.T3.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3 | GPR155 ABCA1 ARHGAP24 HIVEP2 EML4 PECAM1 DMXL1 HEG1 MAST4 TLR1 ZC3H12D | 4.72e-05 | 361 | 148 | 11 | GSM538219_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 1.05e-04 | 107 | 148 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | CD positive, CD19 Control, 19+ 4- 8-, Spleen, avg-6 | GPR155 ABCA1 ARHGAP24 EML4 PECAM1 DMXL1 HEG1 MAST4 TLR1 ZC3H12D | 1.37e-04 | 339 | 148 | 10 | GSM403988_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | NPC1 GALC DSG2 RAB11FIP2 REV3L CSMD3 PANK1 DNAH7 SLC30A5 TAF7L CPNE3 TSHZ1 STX17 CDH2 WNK3 ADGRL3 | 1.57e-04 | 803 | 148 | 16 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.10e-07 | 129 | 152 | 7 | 2f30b4897343586c9b49a1d2bec3007ec737085c | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.12e-06 | 156 | 152 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 164 | 152 | 7 | 0853e75b60b2a78257b660910c3ee15b09c5f5b0 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.98e-06 | 170 | 152 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.50e-06 | 176 | 152 | 7 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.12e-06 | 182 | 152 | 7 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-06 | 184 | 152 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-06 | 184 | 152 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-06 | 184 | 152 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.47e-06 | 185 | 152 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 3.73e-06 | 187 | 152 | 7 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.86e-06 | 188 | 152 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 3.86e-06 | 188 | 152 | 7 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.86e-06 | 188 | 152 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 4.00e-06 | 189 | 152 | 7 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.43e-06 | 192 | 152 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.59e-06 | 193 | 152 | 7 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.74e-06 | 194 | 152 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.74e-06 | 194 | 152 | 7 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.74e-06 | 194 | 152 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.91e-06 | 195 | 152 | 7 | fb3d6a3b10aedc7fdd9789b2c47b4e80fa8e411f | |
| ToppCell | Caecum-T_cell-Tfh|T_cell / Region, Cell class and subclass | 5.07e-06 | 196 | 152 | 7 | fe2ee5788028e6b671674f0cc50e2b6379f50976 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.61e-06 | 199 | 152 | 7 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.61e-06 | 199 | 152 | 7 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.79e-06 | 200 | 152 | 7 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.79e-06 | 200 | 152 | 7 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.79e-06 | 200 | 152 | 7 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 148 | 152 | 6 | e44cdc1c3f3314c549a0afa9298c8568022b9d8b | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.34e-05 | 151 | 152 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 1.61e-05 | 156 | 152 | 6 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-05 | 159 | 152 | 6 | c0e55f25271f788c08fa4b95186501fc27b2ec39 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.14e-05 | 164 | 152 | 6 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.37e-05 | 167 | 152 | 6 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-05 | 169 | 152 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.71e-05 | 171 | 152 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-05 | 172 | 152 | 6 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.80e-05 | 172 | 152 | 6 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-CD163+_Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.80e-05 | 172 | 152 | 6 | 9a659442dc41bd2a4361a7e38a7ee37a39781667 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 176 | 152 | 6 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 177 | 152 | 6 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.28e-05 | 177 | 152 | 6 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.39e-05 | 178 | 152 | 6 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-05 | 179 | 152 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 179 | 152 | 6 | 78fae47ec9bff4e0159a86a281e831d7f8ee925a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.72e-05 | 181 | 152 | 6 | 12ff56fa2949c8d53360cdf2cacfd326e65b54aa | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-05 | 181 | 152 | 6 | 35eefd874a892eaf21f24fdce89e7ea3b8ee285f | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-05 | 181 | 152 | 6 | e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.72e-05 | 181 | 152 | 6 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.72e-05 | 181 | 152 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.08e-05 | 184 | 152 | 6 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.08e-05 | 184 | 152 | 6 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | ILEUM-non-inflamed-(5)_IgG_plasma_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.20e-05 | 185 | 152 | 6 | 93b9a47357152ea95dfdfe8e7d111906a4adc551 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.20e-05 | 185 | 152 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.20e-05 | 185 | 152 | 6 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.20e-05 | 185 | 152 | 6 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 4.20e-05 | 185 | 152 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.33e-05 | 186 | 152 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.33e-05 | 186 | 152 | 6 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.33e-05 | 186 | 152 | 6 | 708c5edefe36c91df27cf53c1b5101fb2030cc5a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.33e-05 | 186 | 152 | 6 | 029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-05 | 186 | 152 | 6 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 4.46e-05 | 187 | 152 | 6 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 4.46e-05 | 187 | 152 | 6 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.46e-05 | 187 | 152 | 6 | 97b2463fb37e7196dd2f92553acf8e7bc3ec40dd | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 4.46e-05 | 187 | 152 | 6 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 4.60e-05 | 188 | 152 | 6 | c7b1807c96f87fbcd37739a159cf00f9a1ff5d71 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-05 | 188 | 152 | 6 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 4.60e-05 | 188 | 152 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.60e-05 | 188 | 152 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.60e-05 | 188 | 152 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.60e-05 | 188 | 152 | 6 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.73e-05 | 189 | 152 | 6 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.73e-05 | 189 | 152 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.73e-05 | 189 | 152 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | e11998c57609c5714705713ac3a32016d6d841dd | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 4.73e-05 | 189 | 152 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 4.73e-05 | 189 | 152 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.87e-05 | 190 | 152 | 6 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 190 | 152 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-05 | 190 | 152 | 6 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.89e-05 | 116 | 152 | 5 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.02e-05 | 191 | 152 | 6 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.02e-05 | 191 | 152 | 6 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.02e-05 | 191 | 152 | 6 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.02e-05 | 191 | 152 | 6 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.02e-05 | 191 | 152 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.02e-05 | 191 | 152 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.02e-05 | 191 | 152 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-05 | 192 | 152 | 6 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-05 | 192 | 152 | 6 | 3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.32e-05 | 193 | 152 | 6 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.32e-05 | 193 | 152 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.32e-05 | 193 | 152 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.32e-05 | 193 | 152 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.32e-05 | 193 | 152 | 6 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.32e-05 | 193 | 152 | 6 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.32e-05 | 193 | 152 | 6 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.32e-05 | 193 | 152 | 6 | ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; PC3; HT_HG-U133A | ABCA1 ITGA10 SETDB1 ARNT SLC30A5 MAST4 ERAP2 AP1G2 XYLB KIF5C | 8.15e-07 | 197 | 151 | 10 | 7148_UP |
| Drug | Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; HL60; HT_HG-U133A | 6.93e-06 | 197 | 151 | 9 | 2991_UP | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; PC3; HT_HG-U133A | 6.93e-06 | 197 | 151 | 9 | 4497_UP | |
| Drug | orthovanadate | ACP6 ABCA1 PDE3B ATP7B MYO7A ACTBL2 RPS6KB2 GRM5 ADCY9 ARNT ATP2C1 ENTPD2 KIF5A | 6.96e-06 | 435 | 151 | 13 | CID000061672 |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.24e-05 | 161 | 151 | 8 | 3556_DN | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 1.02e-05 | 9 | 148 | 3 | DOID:12377 (implicated_via_orthology) | |
| Disease | pigment dispersion syndrome, pigmentary glaucoma | 7.47e-05 | 3 | 148 | 2 | EFO_0021425, MONDO_0010896 | |
| Disease | Colorectal Neoplasms | 8.27e-05 | 277 | 148 | 8 | C0009404 | |
| Disease | reaction time measurement | FOXO3 GPR155 C2orf69 EML4 RAP1GAP2 SLC28A3 BPI ZNF638 TSHZ1 GRIN3A CDH2 EPAS1 | 1.27e-04 | 658 | 148 | 12 | EFO_0008393 |
| Disease | Adenoid Cystic Carcinoma | 1.52e-04 | 100 | 148 | 5 | C0010606 | |
| Disease | visceral adipose tissue measurement | 1.66e-04 | 481 | 148 | 10 | EFO_0004765 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 3.69e-04 | 28 | 148 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | Squamous cell carcinoma of lung | 5.51e-04 | 32 | 148 | 3 | C0149782 | |
| Disease | longevity | 5.99e-04 | 284 | 148 | 7 | EFO_0004300 | |
| Disease | skin pigmentation measurement | 6.52e-04 | 137 | 148 | 5 | EFO_0007009 | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 6.86e-04 | 8 | 148 | 2 | EFO_0800533 | |
| Disease | serum albumin measurement | FAM234B CYP19A1 SLC28A3 IP6K1 ABCA9 ADCY9 ARNT CPT1C HPN MAD1L1 | 8.42e-04 | 592 | 148 | 10 | EFO_0004535 |
| Disease | Colorectal Carcinoma | ABCA1 ABCA3 ATP7B CSMD3 ABCA9 FAT1 ARNT SULT2B1 GNB4 WDR49 FBXW7 | 8.61e-04 | 702 | 148 | 11 | C0009402 |
| Disease | asthma, sex interaction measurement | 8.79e-04 | 9 | 148 | 2 | EFO_0008343, MONDO_0004979 | |
| Disease | 2R,3R-dihydroxybutyrate measurement | 8.79e-04 | 9 | 148 | 2 | EFO_0800314 | |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 1.10e-03 | 10 | 148 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | endometriosis, unipolar depression | 1.32e-03 | 43 | 148 | 3 | EFO_0001065, EFO_0003761 | |
| Disease | electrocardiography | 1.47e-03 | 530 | 148 | 9 | EFO_0004327 | |
| Disease | urinary metabolite measurement | 1.52e-03 | 245 | 148 | 6 | EFO_0005116 | |
| Disease | motor neuron disease (implicated_via_orthology) | 1.60e-03 | 12 | 148 | 2 | DOID:231 (implicated_via_orthology) | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 1.71e-03 | 47 | 148 | 3 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | gallstones | 2.17e-03 | 108 | 148 | 4 | EFO_0004210 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 2.28e-03 | 52 | 148 | 3 | C0023452 | |
| Disease | coronary artery disease | NPC1 KDELR2 NR2C1 ABCA1 HIVEP2 PECAM1 DMXL1 MAST4 MAD1L1 ZC3H12D EML1 COG5 PCCB ADGRL3 | 2.80e-03 | 1194 | 148 | 14 | EFO_0001645 |
| Disease | partial epilepsy | 3.23e-03 | 17 | 148 | 2 | EFO_0004263 | |
| Disease | high altitude adaptation | 3.23e-03 | 17 | 148 | 2 | EFO_0009105 | |
| Disease | Malignant neoplasm of endometrium | 3.63e-03 | 18 | 148 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 3.63e-03 | 18 | 148 | 2 | C0346191 | |
| Disease | mean corpuscular hemoglobin concentration | KNTC1 ATP7B ATR RPS6KB2 XPNPEP1 PFKM CPS1 ADCY9 DMXL1 ZNF638 MAST1 LRIF1 MYO16 | 3.84e-03 | 1105 | 148 | 13 | EFO_0004528 |
| Disease | sexual dimorphism measurement | NPC1 FOXO3 ABCA1 HIVEP2 CYP19A1 RPS6KB2 TECTB CPD ADCY9 SETDB1 ZNF638 GCN1 MNAT1 | 3.87e-03 | 1106 | 148 | 13 | EFO_0021796 |
| Disease | monocyte percentage of leukocytes | 3.91e-03 | 731 | 148 | 10 | EFO_0007989 | |
| Disease | Prostatic Neoplasms | 4.01e-03 | 616 | 148 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.01e-03 | 616 | 148 | 9 | C0376358 | |
| Disease | citrulline measurement | 4.47e-03 | 20 | 148 | 2 | EFO_0009777 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 4.68e-03 | 67 | 148 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | schizophrenia (implicated_via_orthology) | 4.88e-03 | 68 | 148 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Headache, HbA1c measurement | 4.93e-03 | 21 | 148 | 2 | EFO_0004541, HP_0002315 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HGGLTATLVDNISTM | 56 | Q9NPJ3 | |
| VSHMKSLRGTGNTST | 136 | P27540 | |
| SDGTATMTGKHSRVI | 296 | P0CF97 | |
| SVVKSHSITNMEIGG | 866 | Q96RT1 | |
| SKFMGLTQVELTGHS | 116 | Q99814 | |
| DKTTHLLGAFTGASM | 1301 | Q7Z407 | |
| GDLGMQVTSQIHFTK | 356 | Q8N8R5 | |
| TGHKMEFSGQIANLT | 2546 | Q8IZF6 | |
| ESSGIHETTFNSIMK | 271 | Q562R1 | |
| ATFGIVGQKMTTLQH | 396 | Q9H981 | |
| IKTVMFDKTGTITHG | 1021 | P35670 | |
| GHNGAGKSTTIKMIT | 1326 | Q8IUA7 | |
| GHRKFITMSDGATST | 96 | P08910 | |
| FLGHNGAGKTTTMSI | 931 | O95477 | |
| MGHGSTIQLSANTLK | 706 | Q9HAR2 | |
| TLVTMGYSTEHSISG | 226 | O75843 | |
| GSHDLIGTFQTTMTK | 221 | O75131 | |
| GHNGAGKTTTLSMLT | 566 | Q99758 | |
| ASGTSLHQKAIMTFT | 656 | Q4L235 | |
| LTGFVKSHMKSRGDT | 171 | Q8N4G2 | |
| THMSLTGKSGLAGTI | 1836 | Q9Y485 | |
| SDGTANMTGKHSRLT | 211 | Q8TCP9 | |
| TKNEMTVTHIFTSDG | 356 | P98194 | |
| FGNTMSGIHKSFEVL | 1041 | Q8TBY9 | |
| FTLGSEMKLHDSSGS | 1821 | P49792 | |
| EMKLHDSSGSQVGTG | 1826 | P49792 | |
| MEGSVHLITGDSSIN | 346 | P13056 | |
| ASQAGSETLMGFSKH | 66 | Q9H0J4 | |
| SETLMGFSKHGGFTS | 71 | Q9H0J4 | |
| SQGTHTFDPVTKMLS | 326 | P53677 | |
| MKGSSSASIVKGQHE | 696 | Q14126 | |
| KGFQGTTQTSHGSLM | 526 | Q8NDF8 | |
| SIGSFVGMVTAHSQS | 1681 | Q14517 | |
| SGQTDGLTFGHLKMV | 286 | Q08AI8 | |
| VTEGFAHSKITTAMN | 4711 | Q8WXI7 | |
| LQTMHGTTTHFDKIG | 411 | P23469 | |
| TVVRMHVGDGKSSSA | 841 | P41594 | |
| SGSKMQLLETEFSHT | 671 | Q9Y6D9 | |
| VTFSTGIKMGQHISL | 221 | P51948 | |
| MQTTSSRGLVFHTGT | 3016 | Q16787 | |
| SRGLVFHTGTKNSFM | 3021 | Q16787 | |
| QSHGVKIDGLTMQTF | 136 | Q5T3J3 | |
| MLTDVKHFLSSGGNV | 201 | Q9Y6X6 | |
| HLSEMSSVGSKGDFL | 956 | Q9UBC5 | |
| MTKTLPTAVTHGFNS | 16 | Q7Z3F1 | |
| QHTFKQEMTGVGASL | 581 | Q16206 | |
| THGIFTISTASMVEK | 486 | Q92598 | |
| GIVLDAGSSHTSMFI | 41 | Q9Y5L3 | |
| QTMGVSHSFTPKGIT | 6 | Q9GZW8 | |
| FMISKTGEAETITTH | 136 | O43731 | |
| SKSGSHTVAVMNVGA | 396 | P08237 | |
| HQMLKYVSTSESDGT | 581 | Q13370 | |
| ISGIHMQTSESTKSE | 211 | P16284 | |
| VTGTHKMLSAFNATS | 226 | A2RU67 | |
| VSGLSQHTGLAMATE | 1091 | P42356 | |
| FVFATSTTTTLGMHQ | 1866 | P50748 | |
| STTTTLGMHQLTFAH | 1871 | P50748 | |
| QTTTFTGHSGDVMSL | 176 | Q9HAV0 | |
| DLLFHISGVTGKMTT | 1841 | Q92616 | |
| GVMVQTSGKSHAASD | 141 | Q9ULI3 | |
| SFGLEMSQTGFSSHV | 361 | Q9UKX5 | |
| NKGFISSTSLESHMK | 566 | Q9NQV6 | |
| TSFMGNKHIEDTGST | 1161 | Q6R327 | |
| FQAIKTHSEASGMVT | 401 | P05981 | |
| TSMGHIKLTDFGLSK | 506 | Q9Y2H9 | |
| LKMTISQQEFGHTGL | 746 | A2A3N6 | |
| TETLQMGIKHFSGLF | 921 | Q8TCU5 | |
| LAHMGSSVFSGITLT | 1191 | O15118 | |
| QEELGGAKTHTTMSG | 241 | P05166 | |
| RSSSLKVSGTKMGTH | 461 | Q8N264 | |
| KVSGTKMGTHSVQNG | 466 | Q8N264 | |
| DGMITFHISSKKSST | 726 | Q8TCG5 | |
| MHQEDFSGSLSSSGK | 621 | Q9UP83 | |
| TFTTSLENVGSHMTK | 321 | A4D1B5 | |
| LENVGSHMTKGITFL | 326 | A4D1B5 | |
| LMFVNVSGSHEAKGS | 81 | Q13535 | |
| FHGTSSRIGSSMKSV | 781 | P31327 | |
| KDQLSQGTMHTGSTL | 3861 | Q4G0P3 | |
| SRSSTGSMNVTLFHK | 11 | Q9H0H3 | |
| SIDFLLTHKGTGNMV | 166 | Q6E213 | |
| GEETLIISKSSSMFH | 91 | P11511 | |
| QTTTFTGHTGDVMSL | 176 | P62873 | |
| ITGAFSNSVSLKMGH | 316 | Q9H6X5 | |
| SSLASLFLIGMHTTG | 381 | P17213 | |
| GTMKQSSDSHGVDIL | 1396 | O75417 | |
| TIMKSAFSHQGSIQV | 196 | Q5TCH4 | |
| VLSTTGHSTNFVIAM | 3986 | Q8WXX0 | |
| TLTGHQSLTSGMELK | 576 | Q969H0 | |
| MSTGSKKSLLSHEFQ | 1351 | O75976 | |
| SFLGHNGAGKTTTMS | 1021 | Q9BZC7 | |
| HTMGTTISGDNIGKN | 291 | Q8IZF7 | |
| SRSTFLKVGQSIMHG | 306 | O60503 | |
| LTSGEVFGMHTEISI | 151 | Q5I0G3 | |
| HMGVSTDSGTQETKK | 436 | Q86V48 | |
| VTSMGHIKLTDFGLS | 701 | O15021 | |
| SSFGLEMSQIGFSTH | 366 | O75578 | |
| MIISGTTAHFSSKDK | 896 | Q6P179 | |
| MLDGNSGLSSEKISH | 166 | Q92551 | |
| GQTSSGKTHTMEGKL | 86 | Q12840 | |
| DSHLISTGGKDTSIM | 796 | O00423 | |
| DSHLISTGGKDMSII | 846 | Q9HC35 | |
| VSTTGILAGVKMSHA | 1156 | Q14689 | |
| QELKAGTSIMGSHLT | 1001 | Q49AJ0 | |
| GTSIMGSHLTSAETF | 1006 | Q49AJ0 | |
| FMVSKTGEAETITSH | 136 | P24390 | |
| STLMTQKTGIVSGFG | 351 | P00742 | |
| TLTLTIKGHFTSGML | 631 | P54803 | |
| SMHTVHLGVKGTSSL | 2071 | Q6ZTR5 | |
| FMISKTGEAETITTH | 136 | P33947 | |
| QEEGLHAGTMLTTFT | 506 | P19022 | |
| VSTMASFLKGAHVTI | 101 | Q9UJU6 | |
| IQMGSEKNFSSLHTT | 321 | Q8TE04 | |
| LDKLSSMGHQATGTV | 361 | Q8N328 | |
| GLIAVMHTAGTFSLS | 151 | Q8NHC5 | |
| GKSTMFHATVASKTQ | 231 | P41218 | |
| NMGLSESSSLGSAKH | 556 | O43524 | |
| LISSGMSSHKQGHTS | 301 | Q5H9L4 | |
| HQGLVSTLSTASMNG | 616 | Q695T7 | |
| SLSGGISHNSMEVTK | 526 | Q684P5 | |
| ALGSVVAHSTFSAMK | 236 | O00204 | |
| GQTSSGKTHTMEGKL | 86 | O60282 | |
| MLSSQGHIKLTDFGL | 201 | Q9UBS0 | |
| SIVGMFASHAVGSLS | 541 | A1A5C7 | |
| IHDGVSKANFSIGSM | 171 | Q14943 | |
| MATHGVKGTRTTSNN | 1236 | O14802 | |
| KDGSINTSQSMHVGE | 876 | Q13621 | |
| VHVKNGSMGTFESQL | 141 | Q96PL2 | |
| HMSSGLTDLLKTGFS | 596 | Q8WU76 | |
| TKSELHAIMTAGFST | 356 | Q9HAS3 | |
| HAIMTAGFSTIAGSV | 361 | Q9HAS3 | |
| TTTKETLATGHFMSV | 876 | Q6ZRS2 | |
| GGSKEATTTLHMLTL | 296 | Q5JTH9 | |
| HLLFEFKGLMGTSTV | 926 | Q5JTH9 | |
| SSQDLHKGTLSQMSG | 176 | Q15047 | |
| STHGIAIKSTNMASV | 1171 | Q15047 | |
| GNMSQLKFLGLSTTH | 136 | Q15399 | |
| TKGTSAAHLNSMEVT | 66 | Q96F05 | |
| CGKGFTMKSTLSIHQ | 601 | Q8N8J6 | |
| TMKSTLSIHQQTHTG | 606 | Q8N8J6 | |
| HTLSIGDMVTGTVKS | 1031 | Q14690 | |
| VTSTELSSGDQSHKM | 616 | Q92618 | |
| NGVSDFETKSLTMHS | 181 | Q86XZ4 | |
| KDGTTDVTRTMHFGT | 421 | Q9NQW7 | |
| SKTSNIGLSMEFHGN | 171 | Q9C0E2 | |
| STAQHVFKVSLVSGM | 96 | O60673 | |
| KDTTTSTEQMLSHGT | 691 | Q12767 | |
| NSQGTSTDMLTIGHK | 391 | Q6ZVD7 | |
| LTRSMTVGGAFHTTE | 131 | P56962 | |
| LAHSGVGSIIMSTDK | 416 | Q8IV35 | |
| MSKTKILATGGASHN | 431 | O75191 | |
| HETTLKGGMFAGQLT | 111 | Q9NPH0 | |
| MSSEKLKAGTIGQTH | 236 | Q7L804 | |
| GSNVAMSHGNKETFS | 96 | A2A288 | |
| TSDKMQHFKRTGTGT | 1006 | Q9H582 | |
| ILMFGGTSSNSVKQT | 11 | A0A0B4J280 | |
| SGLSTGFHDVLAMTK | 736 | Q8TAD4 | |
| IFDMKSISGEESSHG | 236 | Q9UL58 | |
| TTITGASESVGKHML | 21 | O94888 | |
| KSTHLIGSGSEKMNI | 351 | Q9BR11 | |
| SAVIKMSTFGSHEGQ | 31 | P31629 | |
| GISSSSVLHGMVFKK | 211 | P50990 | |
| MVTGHFLKVTTSASK | 436 | Q6ZSZ6 | |
| SVESGTKMSGLHISG | 286 | Q14966 | |
| QSAKMTSFGIEHISV | 1346 | Q9BYP7 | |
| FDKVSSLGSGSDHVM | 1306 | Q13402 |